Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension

M Iriarte1, N Murga, D Sagastagoitia

  • 1University of the Basque Country, Institute of Cardiology, Hospital Civil de Basurto, Bilbao (Bizkaia), Spain.

Insights

Congestive heart failure with normal ejection fraction in hypertensive patients presents two distinct profiles: one with severe hypertrophy and another with significant myocardial ischemia. Treatment should target the specific underlying cause for better outcomes.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Hypertension Research

Background:

  • Congestive heart failure (CHF) with preserved ejection fraction (HFpEF) was previously considered clinically uniform.
  • Distinguishing HFpEF profiles is crucial for targeted therapeutic strategies.

Purpose of the Study:

  • To investigate distinct clinical and pathophysiological profiles within hypertensive patients experiencing CHF with normal ejection fraction.
  • To identify subgroups within HFpEF based on echocardiographic hypertrophy and myocardial ischemia.

Main Methods:

  • Studied 36 hypertensive patients with recent CHF and normal ejection fraction (> or = 50%).
  • Divided patients into two groups based on ventricular mass/volume ratio (Group A: >1.8, Group B: <1.8).
  • Utilized echocardiography, thallium-201 scintigraphy, and clinical assessments (auscultation, cardiothoracic ratio).

Main Results:

  • Group A (high hypertrophy) showed higher ejection fraction, smaller ventricular diameters, and lower thallium-201 positivity (indicating less ischemia).
  • Group B (less hypertrophy) had a higher rate of myocardial ischemia, evidenced by thallium-201 uptake and coronary stenosis.
  • Clinical findings differentiated groups: Group A had more S4 sounds and smaller cardiothoracic ratios; Group B had more S3 sounds.

Conclusions:

  • Hypertensive CHF with normal ejection fraction manifests as two distinct phenotypes: one dominated by severe left ventricular hypertrophy and the other by significant myocardial ischemia.
  • Therapeutic approaches should be tailored: regression of hypertrophy for the first profile and improvement of ischemia for the second.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...